Login / Signup

Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction.

Alberto Esteban-FernándezInés Gómez-OteroSilvia López-FernándezMiguel Rodríguez SantamartaFrancisco J Pastor-PérezPaula Fluvià-BruguésJosé-Ángel Pérez-RiveraAndrea López LópezJosé Manuel García-PinillaJuan Luis Bonilla PalomasLuis Almenar BonetMarta Cobo-MarcosVirgilio Martínez MateoJavier Torres LlergoVanesa Alonso FernándezCristina Goena VivesJavier de Juan BagudáAlba Maestro BenedictoJosé Ignacio Morgado de PolaviejaItziar Solla-RuizEduard Solé-GonzálezMontserrat CardonaJavier Rekondo OlaetxeaCarolina Ortiz CortésVictor Martínez DosantosAntonio Gámez LópezElvis AmaoBorja Casas SánchezEdgardo Alania TorresVíctor Gómez CarrilloDaniel García-FuertesFrancisco Ridocci-Sorianonull null
Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)
It is possible to achieve quadruple therapy in patients with newly diagnosed HFrEF early. This strategy makes it possible to reduce admissions and visits to the emergency room for HF without associating a more significant reduction or withdrawal of drugs or significant difficulty in achieving the target doses.
Keyphrases
  • newly diagnosed
  • healthcare
  • helicobacter pylori
  • emergency department
  • public health
  • helicobacter pylori infection
  • stem cells
  • mesenchymal stem cells
  • smoking cessation
  • acute heart failure
  • cell therapy
  • drug induced